Investor Alert

New York Markets Close in:

ICU Medical Inc.



Countdown to close

 --Real time quotes

May 17, 2022, 3:56 p.m.





+4.80 +2.66%


Volume 132,706

Real time quotes


Previous close

$ 180.75

$ 185.55


+4.80 +2.66%

Day low

Day high




52 week low

52 week high




Annual Financials for ICU Medical Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries 68.64M28.79M101.04M86.87M103.14M
Depreciation, Depletion & Amortization 66.57M74.74M85.21M94.85M99.29M
Depreciation and Depletion 51.57M58.14M67.51M71.65M75.49M
Amortization of Intangible Assets 15M16.6M17.7M23.2M23.8M
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds (36.68M)82.09M27.31M58M50.07M
Funds from Operations 98.54M185.62M213.55M239.72M252.5M
Extraordinaries -----
Changes in Working Capital 55.89M(25.41M)(111.64M)(16.97M)15.04M
Receivables (149.84M)20.7M(23.68M)78.05M13.76M
Accounts Payable 46.65M23.27M(2.7M)(46.42M)2.35M
Other Assets/Liabilities (56.43M)(18.05M)(16.57M)(38.42M)(28.14M)
Net Operating Cash Flow 154.42M160.22M101.92M222.75M267.54M

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures (79.68M)(100.78M)(106.04M)(100.39M)(81.17M)
Capital Expenditures (Fixed Assets) (74.48M)(92.72M)(97.31M)(92.01M)(68.54M)
Capital Expenditures (Other Assets) (5.2M)(8.06M)(8.73M)(8.39M)(12.63M)
Net Assets from Acquisitions (162.45M)(1.3M)(76.13M)-(14.45M)
Sale of Fixed Assets & Businesses 2,00013.77M33,0006.18M218,000
Purchase/Sale of Investments (24.74M)(15.06M)15.25M(3.93M)4.72M
Purchase of Investments (24.74M)(30.5M)(26.04M)(32.83M)(13.28M)
Sale/Maturity of Investments -15.44M41.29M28.9M18M
Other Uses -----
Other Sources -----
Net Investing Cash Flow (266.87M)(103.37M)(166.89M)(98.14M)(90.69M)

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 30.65M8.02M(10.91M)317,0001.04M
Repurchase of Common & Preferred Stk. (4.06M)(6.25M)(18.64M)(12.88M)(8.34M)
Sale of Common & Preferred Stock 34.71M14.28M7.73M13.19M9.37M
Proceeds from Stock Options 2.71M----
Other Proceeds from Sale of Stock 32M14.28M7.73M13.19M9.37M
Issuance/Reduction of Debt, Net (75M)--(357,000)(607,000)
Change in Current Debt -----
Change in Long-Term Debt (75M)--(357,000)-
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt (75M)--(357,000)(607,000)
Other Funds ----(17.3M)
Other Uses ----(17.3M)
Other Sources -----
Net Financing Cash Flow (44.35M)8.02M(10.91M)(40,000)(16.87M)
Exchange Rate Effect 1.79M(10.16M)(234,000)2.85M(3.25M)
Miscellaneous Funds -----
Net Change in Cash (155.01M)54.71M(76.11M)127.43M156.73M
Free Cash Flow 79.94M67.5M4.61M130.75M199M
Link to MarketWatch's Slice.